Cargando…

Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment

SIMPLE SUMMARY: The intent of this paper is to critically revise the epidemiology, etiology, main clinical features, histopathology, immunophenotype, molecular characteristics, prognosis, and therapeutic options of peripheral T-cell lymphoma, not otherwise specified (PTCL_NOS). PTCL_NOS represents t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pileri, Stefano A., Tabanelli, Valentina, Fiori, Stefano, Calleri, Angelica, Melle, Federica, Motta, Giovanna, Lorenzini, Daniele, Tarella, Corrado, Derenzini, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472517/ https://www.ncbi.nlm.nih.gov/pubmed/34572763 http://dx.doi.org/10.3390/cancers13184535

Ejemplares similares

Dissecting diffuse large B-cell lymphomas of the “not otherwise specified” type: the impact of molecular techniques
por: Pileri, Stefano A, et al.
Publicado: (2018)

Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
por: Sapienza, Maria Rosaria, et al.
Publicado: (2019)

Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
por: Laginestra, Maria Antonella, et al.
Publicado: (2019)

Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
por: Laginestra, Maria Antonella, et al.
Publicado: (2019)

Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
por: Pileri, Stefano A., et al.
Publicado: (2021)

Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
por: Rossi, Alessandra, et al.
Publicado: (2021)

The identification of TCF1(+) progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
por: Tabanelli, Valentina, et al.
Publicado: (2022)

Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified
por: Laginestra, M A, et al.
Publicado: (2014)

A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma
por: Derenzini, Enrico, et al.
Publicado: (2020)

Peripheral T Cell Lymphoma: Not Otherwise Specified
por: Pai, Anusha H, et al.
Publicado: (2015)

Peripheral T-cell lymphoma, not otherwise specified
por: Jha, Kunal Kishor, et al.
Publicado: (2017)

Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies
por: Agostinelli, C, et al.
Publicado: (2008)

Eosinophilic Fasciitis with Hypereosinophilia as the Initial Clinical Manifestation of Peripheral T-Cell Lymphoma, Not Otherwise Specified
por: Okuyama, Shuhei, et al.
Publicado: (2022)

Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
por: Mazzara, Saveria, et al.
Publicado: (2022)

Peripheral T-cell lymphoma, not otherwise specified- Case report
por: Khan, Nariman, et al.
Publicado: (2020)

Peripheral T-cell Lymphoma, Not Otherwise Specified: An Unusual Presentation of a Rare Lymphoma
por: Singh, Aditi, et al.
Publicado: (2019)

Sarcoidosis-Lymphoma Syndrome Associated with Folliculotropic Peripheral T Cell Lymphoma Not Otherwise Specified
por: Yoshida, Saaya, et al.
Publicado: (2017)

Symptom Profiles in Psychotic Disorder Not Otherwise Specified
por: Widing, Line, et al.
Publicado: (2020)

Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
por: Ji, Meng-Meng, et al.
Publicado: (2018)

Paraneoplastic hypereosinophilia in a patient with peripheral T cell lymphoma, not otherwise specified
por: Desmirean, Minodora, et al.
Publicado: (2019)

Peripheral T-Cell Lymphoma-Not Otherwise Specified Presenting as Disfiguring Facial Swelling
por: Bandyopadhyay, Arghya, et al.
Publicado: (2021)

A Rare Case of Aggressive Peripheral T-cell Lymphoma–Not Otherwise Specified
por: Rahman, Ateeb Ur, et al.
Publicado: (2022)

A Giant Mass in the Eyelid: Peripheral T-Cell Lymphoma, Not Otherwise Specified
por: Yuksel, Nilay, et al.
Publicado: (2023)

Plasmablastic lymphoma: one or more tumors?
por: Pileri, Stefano A., et al.
Publicado: (2021)

Identification of multiple subclones in peripheral T-cell lymphoma, not otherwise specified with genomic aberrations
por: Yoshida, Noriaki, et al.
Publicado: (2012)

Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case
por: Muroya, Daisuke, et al.
Publicado: (2014)

Peripheral T-cell lymphoma, not otherwise specified, presenting with generalized ulcerated plaques and hypereosinophilia
por: Jani, Aditi, et al.
Publicado: (2018)

Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma
por: Kim, Tong-Yoon, et al.
Publicado: (2022)

Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network
por: Federico, Massimo, et al.
Publicado: (2018)

Pralatrexate for Prolonged Treatment of Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, with Prophylactic Leucovorin
por: Kitazume, Koichi, et al.
Publicado: (2019)

Successful response with romidepsin in relapsed peripheral T-cell lymphoma, not otherwise specified with leukemic progression
por: Sato, Shuku, et al.
Publicado: (2020)

Peripheral T-Cell Lymphoma, Not Otherwise Specified – a case report and short literature review
por: de Figueiredo, Rafael Henriques, et al.
Publicado: (2022)

Diffuse large B-cell lymphoma, not otherwise specified of the palate: A case report
por: Souto, Giovanna R., et al.
Publicado: (2013)

HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases
por: Fiori, Stefano, et al.
Publicado: (2021)

Chemotherapy Plus Radiotherapy Versus Chemotherapy Alone for Patients With Peripheral T-Cell Lymphoma, Not Otherwise Specified
por: Chen, Zegeng, et al.
Publicado: (2021)

BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified
por: Marques-Piubelli, Mario L., et al.
Publicado: (2021)

Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report
por: Wu, Miao-Miao, et al.
Publicado: (2022)

Primary Cutaneous Peripheral T-Cell Lymphoma Not Otherwise Specified: A Rapidly Progressive Variant of Cutaneous T-Cell Lymphoma
por: Aderhold, Kimberly, et al.
Publicado: (2015)

Prognostic indices for peripheral T-cell lymphoma - not otherwise specified and adult T-cell leukemia/lymphoma: From past to future
por: Ishitsuka, Kenji
Publicado: (2023)

Skin Infiltration of Nodal Peripheral T-Cell Lymphoma-not Otherwise Specified Identified by Skin Biopsy of Faint Eruptions
por: Isohisa, Taro, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i35a5mqknn4vod7mhu8q7es1dp